| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrobiologics, Inc. (FBLG) has 8 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. FBLG is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 180.0K | $203.4K | - | |
| CFO | 70.0K | $79.1K | - | |
| Other | 61.3K | $69.2K | - | |
| Dir | 22.0K | $24.9K | - | |
| Dir | 22.0K | $24.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Khoja Hamid | Chief Scientific Officer | Buy | 30,000 | $0.38 | $11,400.00 | +96.0% | - | - | |
| Mar 2, 2026 | Davis Jason | Chief Financial Officer | Buy | 70,000 | $0.41 | $28,973.00 | New | - | - | |
| Feb 27, 2026 | Garcia Ruben A | General Counsel | Buy | 40,000 | $0.33 | $13,056.00 | +28.6% | - | - | |
| Dec 11, 2025 | Garcia Ruben A | General Counsel | Buy | 140,000 | $0.34 | $47,600.00 | New | -2.2% | - | |
| May 27, 2025 | Khoja Hamid | Chief Scientific Officer | Buy | 20,000 | $0.84 | $16,800.00 | +177.8% | -24.7% | - | |
| Aug 12, 2024 | O'Heeron Pete | Chief Executive Officer | Buy | 8,500 | $1.91 | $16,269.00 | +0.1% | +88.5% | -68.6% | |
| Aug 12, 2024 | Khoja Hamid | Chief Scientific Officer | Buy | 10,000 | $1.90 | $19,000.00 | +800.0% | +88.5% | -68.6% |